1. Home
  2. STKH vs DRMA Comparison

STKH vs DRMA Comparison

Compare STKH & DRMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • STKH
  • DRMA
  • Stock Information
  • Founded
  • STKH 2018
  • DRMA 2014
  • Country
  • STKH Israel
  • DRMA United States
  • Employees
  • STKH N/A
  • DRMA N/A
  • Industry
  • STKH Packaged Foods
  • DRMA Biotechnology: Pharmaceutical Preparations
  • Sector
  • STKH Consumer Staples
  • DRMA Health Care
  • Exchange
  • STKH Nasdaq
  • DRMA Nasdaq
  • Market Cap
  • STKH 4.9M
  • DRMA 4.5M
  • IPO Year
  • STKH 2021
  • DRMA 2021
  • Fundamental
  • Price
  • STKH $0.66
  • DRMA $0.75
  • Analyst Decision
  • STKH
  • DRMA Strong Buy
  • Analyst Count
  • STKH 0
  • DRMA 1
  • Target Price
  • STKH N/A
  • DRMA $6.00
  • AVG Volume (30 Days)
  • STKH 43.1K
  • DRMA 4.2M
  • Earning Date
  • STKH 03-31-2025
  • DRMA 05-14-2025
  • Dividend Yield
  • STKH N/A
  • DRMA N/A
  • EPS Growth
  • STKH N/A
  • DRMA N/A
  • EPS
  • STKH N/A
  • DRMA N/A
  • Revenue
  • STKH $10,000.00
  • DRMA N/A
  • Revenue This Year
  • STKH N/A
  • DRMA N/A
  • Revenue Next Year
  • STKH N/A
  • DRMA N/A
  • P/E Ratio
  • STKH N/A
  • DRMA N/A
  • Revenue Growth
  • STKH N/A
  • DRMA N/A
  • 52 Week Low
  • STKH $0.60
  • DRMA $0.69
  • 52 Week High
  • STKH $4.64
  • DRMA $6.17
  • Technical
  • Relative Strength Index (RSI)
  • STKH 29.03
  • DRMA 34.82
  • Support Level
  • STKH $0.60
  • DRMA $0.69
  • Resistance Level
  • STKH $0.78
  • DRMA $0.85
  • Average True Range (ATR)
  • STKH 0.12
  • DRMA 0.08
  • MACD
  • STKH 0.00
  • DRMA -0.00
  • Stochastic Oscillator
  • STKH 16.45
  • DRMA 21.43

About STKH Steakholder Foods Ltd.

Steakholder Foods Ltd is engaged in transforming the alternative protein industries through its technology. The group specializes in developing and selling 3D-printing production machines, supported by proprietary premix blends, formulated from the highest-quality raw ingredients. These tools help manufacturers of all sizes efficiently produce foods that meet consumer expectations for taste, texture, and appearance and offer a safe and sustainable alternative to industrialized meat and seafood production. The company's expertise in creating alternative protein products replicating traditional meats' complex textures such as beef steaks, white fish, shrimp, and eel. It also explores the integration of cultivated cells, preparing for future advancements in food technology.

About DRMA Dermata Therapeutics Inc.

Dermata Therapeutics Inc. is a clinical-stage medical dermatology company focused on identifying, developing, and commercializing pharmaceutical product candidates for the treatment of medical and aesthetic skin conditions and diseases. Its two product candidates, DMT310 and DMT410, incorporate its proprietary, multifaceted, Spongilla technology to topically treat a variety of dermatological conditions. Its Spongilla technology platform will enable to development and formulation of singular and combination products that can target topical delivery of chemical compounds into the dermis for maximum treatment effect for a variety of inflammatory skin diseases.

Share on Social Networks: